PL2672962T3 - Nowa kompozycja przeciwgrzybicza - Google Patents

Nowa kompozycja przeciwgrzybicza

Info

Publication number
PL2672962T3
PL2672962T3 PL12703537T PL12703537T PL2672962T3 PL 2672962 T3 PL2672962 T3 PL 2672962T3 PL 12703537 T PL12703537 T PL 12703537T PL 12703537 T PL12703537 T PL 12703537T PL 2672962 T3 PL2672962 T3 PL 2672962T3
Authority
PL
Poland
Prior art keywords
antifungal composition
novel antifungal
novel
composition
antifungal
Prior art date
Application number
PL12703537T
Other languages
English (en)
Inventor
Åke Lindahl
Original Assignee
Moberg Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moberg Pharma Ab filed Critical Moberg Pharma Ab
Publication of PL2672962T3 publication Critical patent/PL2672962T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
PL12703537T 2011-02-11 2012-02-10 Nowa kompozycja przeciwgrzybicza PL2672962T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1150107 2011-02-11
PCT/EP2012/052327 WO2012107565A1 (en) 2011-02-11 2012-02-10 Novel antifungal composition
EP12703537.6A EP2672962B1 (en) 2011-02-11 2012-02-10 Novel antifungal composition

Publications (1)

Publication Number Publication Date
PL2672962T3 true PL2672962T3 (pl) 2015-08-31

Family

ID=45581892

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12703537T PL2672962T3 (pl) 2011-02-11 2012-02-10 Nowa kompozycja przeciwgrzybicza

Country Status (25)

Country Link
US (3) US8952070B2 (pl)
EP (1) EP2672962B1 (pl)
JP (1) JP5883886B2 (pl)
KR (1) KR101647545B1 (pl)
CN (2) CN109453150A (pl)
AU (1) AU2012215383B2 (pl)
BR (1) BR112013020456B1 (pl)
CA (1) CA2826741C (pl)
CY (1) CY1116275T1 (pl)
DK (1) DK2672962T3 (pl)
ES (1) ES2535827T3 (pl)
HK (1) HK1190944A1 (pl)
HR (1) HRP20150507T1 (pl)
IL (1) IL227765A (pl)
ME (1) ME02152B (pl)
MX (1) MX335945B (pl)
PL (1) PL2672962T3 (pl)
PT (1) PT2672962E (pl)
RS (1) RS53982B1 (pl)
RU (1) RU2587064C2 (pl)
SG (1) SG192615A1 (pl)
SI (1) SI2672962T1 (pl)
SM (1) SMT201500154B (pl)
WO (1) WO2012107565A1 (pl)
ZA (1) ZA201305891B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2672962T3 (pl) 2011-02-11 2015-08-31 Moberg Pharma Ab Nowa kompozycja przeciwgrzybicza
EP2728442B1 (en) 2012-08-30 2016-06-08 Huawei Device Co., Ltd Method and device for controlling central processing unit
CN108135844A (zh) * 2015-10-07 2018-06-08 埃克索多斯生命科学有限合伙公司 局部用抗真菌组合物
US10543276B2 (en) 2016-08-08 2020-01-28 Marlinz Pharma, LLC Topical compositions
US10251858B1 (en) 2016-08-08 2019-04-09 Marlinz Pharma, LLC Composition for treating fungal infections in nails
EP3292758A1 (en) 2016-09-07 2018-03-14 Rottapharm S.p.A. Antimicrobial composition comprising a carboxylic acid and two diols
EP3784204B1 (en) * 2018-04-27 2023-12-13 Unigroup ApS Kit of parts for nail fungus
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
AU2021396584A1 (en) 2020-12-08 2023-07-20 Moberg Pharma Ab Treatment regimen for onchyomycosis using allylamine antifungal compositions

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US6165484A (en) 1997-08-26 2000-12-26 Wake Forest University EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
AUPP146598A0 (en) * 1998-01-21 1998-02-12 Health And Hygiene International Pty Ltd Fruit and vegetable wash
DE19921794A1 (de) * 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
CN1678277B (zh) * 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
PL373235A1 (pl) * 2002-09-05 2005-08-22 Galderma S.A. Roztwór do stosowania na paznokcie
JP5059408B2 (ja) * 2004-08-05 2012-10-24 久光製薬株式会社 爪用外用剤
US20060078599A1 (en) 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
CN1939539A (zh) * 2005-09-29 2007-04-04 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
CA2640889A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
WO2007106622A2 (en) * 2006-02-03 2007-09-20 Carl Lawyer Fungicidal formulation and method of use
WO2007094999A2 (en) * 2006-02-13 2007-08-23 Stiefel Laboratories, Inc. Ungual antifungal compositions
US20080038219A1 (en) 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
AU2007355106A1 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
EP2526928B1 (en) * 2007-02-05 2018-12-26 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
WO2009140215A2 (en) 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
PE20110642A1 (es) * 2008-07-23 2011-08-31 Tdt Ltd Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso
US8524258B2 (en) * 2008-12-22 2013-09-03 Johnson & Johnson Consumer Companies, Inc. Structured lotions
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
KR20120038444A (ko) * 2009-08-13 2012-04-23 모베르그 데르마 아베 네일의 진균 감염 치료를 위한 조성물 및 방법
WO2011079234A2 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
WO2012017371A1 (en) * 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it
PL2672962T3 (pl) 2011-02-11 2015-08-31 Moberg Pharma Ab Nowa kompozycja przeciwgrzybicza

Also Published As

Publication number Publication date
CN103384518B (zh) 2018-10-26
CN103384518A (zh) 2013-11-06
PT2672962E (pt) 2015-05-25
RU2013136147A (ru) 2015-03-20
HRP20150507T1 (hr) 2015-06-19
US20170258914A1 (en) 2017-09-14
ME02152B (me) 2015-10-20
IL227765A (en) 2016-09-29
CA2826741C (en) 2016-03-29
JP2014508146A (ja) 2014-04-03
MX2013009245A (es) 2013-12-09
JP5883886B2 (ja) 2016-03-15
BR112013020456A2 (pt) 2016-10-18
EP2672962A1 (en) 2013-12-18
KR20140025341A (ko) 2014-03-04
US8952070B2 (en) 2015-02-10
RU2587064C2 (ru) 2016-06-10
AU2012215383B2 (en) 2016-06-09
US20140031430A1 (en) 2014-01-30
KR101647545B1 (ko) 2016-08-10
SG192615A1 (en) 2013-09-30
ZA201305891B (en) 2015-06-24
AU2012215383A1 (en) 2013-08-29
EP2672962B1 (en) 2015-03-25
SMT201500154B (it) 2015-09-07
US20150250878A1 (en) 2015-09-10
SI2672962T1 (sl) 2015-06-30
MX335945B (es) 2016-01-04
IL227765A0 (en) 2013-09-30
US9561279B2 (en) 2017-02-07
CA2826741A1 (en) 2012-08-16
WO2012107565A1 (en) 2012-08-16
DK2672962T3 (en) 2015-04-20
HK1190944A1 (en) 2014-07-18
BR112013020456B1 (pt) 2020-01-21
CN109453150A (zh) 2019-03-12
ES2535827T3 (es) 2015-05-18
CY1116275T1 (el) 2017-02-08
RS53982B1 (en) 2015-10-30

Similar Documents

Publication Publication Date Title
ZA201400330B (en) Novel composition
ZA201308399B (en) Improved composition
PL2680698T3 (pl) Nowe kompozycje grzybobójcze
HK1190944A1 (en) Novel antifungal composition
EP2730619A4 (en) COMPOSITION
HRP20181667T1 (hr) Pripravak
EP2692796A4 (en) COMPOSITION
GB201120616D0 (en) Composition
IL231660A0 (en) preparation
GB201119601D0 (en) Composition
EP2611453A4 (en) ANTIFUNGAL COMPOSITION
HK1201029A1 (en) Composition
GB201121258D0 (en) Composition
GB201108912D0 (en) Composition
GB201103964D0 (en) Composition
GB201204957D0 (en) Composition
GB201115211D0 (en) Composition
GB201121300D0 (en) Novel composition
GB201216884D0 (en) Composition
LT2726579T (lt) Kompozicija
GB201322023D0 (en) Composition
EP2711011A4 (en) PANAXADIUM-CONTAINING COMPOSITION
GB201118701D0 (en) Composition
GB201107756D0 (en) Novel composition
GB201118516D0 (en) Composition